1. Repository of OAI
  2. ΑΠΟΘΕΤΗΡΙΟ "ΟΛΥΜΠΙΑΣ"
  3. Σχολή Θετικών Επιστημών
  4. Τμήμα Χημείας
  5. Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ
Ελληνικά   English  
Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/8948
Full metadata record
DC FieldValueLanguage
dc.contributor.authorZhou, M. K.en
dc.contributor.authorKostoula, I.en
dc.contributor.authorBrill, B.en
dc.contributor.authorPanou, E.en
dc.contributor.authorSakarellos-Daitsiotis, M.en
dc.contributor.authorDietrich, U.en
dc.date.accessioned2015-11-24T16:45:32Z-
dc.date.available2015-11-24T16:45:32Z-
dc.identifier.issn0264-410X-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/8948-
dc.rightsDefault Licence-
dc.subjecthiv-1en
dc.subjectgp41en
dc.subjectepitopesen
dc.subjectsequential oligopeptide carriersen
dc.subjectimmunogensen
dc.subjectneutralizing antibodiesen
dc.subjectimmunodeficiency-virus type-1en
dc.subjecthuman monoclonal-antibodiesen
dc.subjectmacaquesen
dc.subjectdesignen
dc.subject2f5en
dc.subjectinfectionen
dc.subjectcarriersen
dc.subjectbroaden
dc.subjectspecificitiesen
dc.subjectglycoproteinen
dc.titlePrime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in miceen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primaryDOI 10.1016/j.vaccine.2012.01.026-
heal.identifier.secondary<Go to ISI>://000302662800001-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Θετικών Επιστημών. Τμήμα Χημείαςel
heal.publicationDate2012-
heal.abstractPeptide mimics of epitopes for pathogen-specific antibodies present in patient sera can be selected based on the phage display technology. Such mimotopes potentially represent vaccine candidates in case they are able to induce neutralizing antibodies upon vaccination. Here we analyze the immunogenicity of different conjugates of epitope EC26-2A4 localizing to the membrane proximal external region (MPER) of the HIV-1 transmembrane protein gp41. The EC26-2A4 epitope, which overlaps with that of the broadly neutralizing monoclonal antibody (mAb) 2F5, was coupled to sequential oligopeptide carriers (SOC) or to palmitoyl acid for better immunogenicity. Upon prime-boost immunizations of mice, the peptide conjugates induced EC26-2A4 specific antibodies in all settings and mice sera neutralized HIV-1SF162.LS in standardized neutralization assays. Thus, the EC26-2A4 MPER epitope represents a promising vaccine candidate for further analysis in larger animals with respect to the breadth of the neutralizing antibodies induced. (C) 2012 Elsevier Ltd. All rights reserved.en
heal.publisherElsevieren
heal.journalNameVaccineen
heal.journalTypepeer reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά). ΧΗΜ

Show simple item record
Files in This Item:
File Description SizeFormat 
Panou-2012-Prime boost vaccination.pdf411.4 kBAdobe PDFView/Open    Request a copy
Show simple item record  


This item is licensed under a Creative Commons License Creative Commons